Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Pharmaceutical Preparations · Hyderabad, IN · filing with the SEC since 2001
Who owns Dr. Reddy's Laboratories Limited
As filed with the SECHolders of 5% or more
1
K. Satish Reddy holds 13.6% of American depositary shares, each representing one equity share, as its SCHEDULE 13D/A filed Sep 18, 2025 says.
Directors and officers
19
report now, of 19 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
K. Satish Reddy
SCHEDULE 13D/A · filed Sep 18, 2025 · American depositary shares, each representing one equity share
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 28, 2025 · Common Stock · reported falling below 5%
What RDY reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Aurigene Discovery Technologies Malaysia Sdn. Bhd.
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
Aurigene Oncology Limited (formerly Aurigene Discovery Technologies Limited)
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
Aurigene Pharmaceutical Services Limited
An entity · related party, subsidiary · owns, named in the 20-F filed May 29, 2026
beta Institut gemeinnutzige GmbH
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
betapharm Arzneimittel GmbH
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
Cheminor Investments Limited
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
Clean Renewable Energy KK 2A Private Limited From July 31 2024
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
Dr Reddys Beijing Pharmaceutical Co Limited
An entity · subsidiary · owns, named in the 20-F filed May 29, 2026
62 subsidiaries in 33 countries, from the list filed with the 20-F filed May 29, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.